Intraocular Lenses
Jun 26, 2025
GE HealthCare Receives FDA Approval for Expanded Vizamyl PET Imaging Indications in Alzheimer’s Disease Care; FDA Grants Approval to InspireMD’s CGuard® Prime for Carotid Artery Disease; AngioDynamics Launches RECOVER-AV Trial, Marking Milestone in AlphaVac F18⁸⁵ Development for PE Treatment; Tivic Health Concludes Study Optimizing Non-Invasive Vagus Nerve Stimulation Device for Personalized Therapy; Johnson & Johnson Introduces VOLT™ Plating System and ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM in the U.S.
GE HealthCare Announced that the FDA Approved Expanded Indications for Vizamyl Pet Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients On June 24, 2025, GE HealthCare announced that the U.S. Food and Drug Administration (FDA) approved an updated label for its PET i...
Read More...
Jun 25, 2025
Myopia Medical Devices That Are Transforming Vision Care
Picture a world where billions struggle to see the stars clearly, where distant landscapes fade into a blur. This is the reality for approximately 2.6 billion people globally living with myopia, a number expected to nearly double to 4.8 billion by 2050, according to the World Health Organization. Myopia, or nearsig...
Read More...
Oct 05, 2022
How is Vision Care Market Growing With the Ongoing Innovation in the Product Development?
The eyes are one of the most vital and critical body parts that provide aids in the processing of visual details. Being a very sensitive and delicate part, they require special care. Eyes defects can affect everyday activities and severely impact individuals and their families social and economic well-being. As per...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
